Xilio Therapeutics promotes Christopher Frankenfield to COO; $500k salary, 150k option grant

Xilio Therapeutics, Inc.

Christopher Frankenfield promoted from Chief Legal & Admin Officer to COO effective Aug 3, 2023.
New annual base salary of $500,000; target bonus set at 50% of base salary.
Granted option to purchase 150,000 shares of common stock, vesting monthly over 4 years.
Frankenfield previously served as Chief Legal & Admin Officer since Aug 2022 and at Blueprint Medicines.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Christopher Frankenfield

Chief Operating Officer

XLO · Xilio Therapeutics, Inc.

Effective: 2023-08-03
Filed: August 3, 2023, 7:59 PM ET

On August 3, 2023, the board of directors (the “Board”) of Xilio Therapeutics, Inc. (the “Company”) promoted Christopher Frankenfield, the Company’s Chief Legal and Administrative Officer, to the position of Chief Operating Officer, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher Frankenfield changed role as Chief Operating Officer at Xilio Therapeutics, Inc..

Action: promoted
Role: Chief Operating Officer

Exact text from the filing

On August 3, 2023, the board of directors (the “Board”) of Xilio Therapeutics, Inc. (the “Company”) promoted Christopher Frankenfield, the Company’s Chief Legal and Administrative Officer, to the position of Chief Operating Officer, effective immediately.

View on SEC.gov

Xilio Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-23-013235

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.